Alchemy Investments Acquisition Corp 1 Class A Ordinary Shares (NASDAQ:ALCY) — Market Cap & Net Worth
Market Cap & Net Worth: Alchemy Investments Acquisition Corp 1 Class A Ordinary Shares (ALCY)
Alchemy Investments Acquisition Corp 1 Class A Ordinary Shares (NASDAQ:ALCY) has a market capitalization of $50.20 Million ($50.20 Million) as of August 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #21810 globally and #4801 in its home market, demonstrating a 1.97% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Alchemy Investments Acquisition Corp 1 Class A Ordinary Shares's stock price $11.93 by its total outstanding shares 4208042 (4.21 Million). Review Alchemy Investments Acquisition Corp 1 C (ALCY) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.
Alchemy Investments Acquisition Corp 1 Class A Ordinary Shares Market Cap History: 2023 to 2026
Alchemy Investments Acquisition Corp 1 Class A Ordinary Shares's market capitalization history from 2023 to 2026. Data shows growth from $43.89 Million to $50.20 Million (5.12% CAGR).
Index Memberships
Alchemy Investments Acquisition Corp 1 Class A Ordinary Shares is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Composite
IXIC
|
$40.26 Trillion | 0.00% | #2086 of 3165 |
Weight: Alchemy Investments Acquisition Corp 1 Class A Ordinary Shares's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Alchemy Investments Acquisition Corp 1 Class A Ordinary Shares Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Alchemy Investments Acquisition Corp 1 Class A Ordinary Shares's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of ALCY by Market Capitalization
Companies near Alchemy Investments Acquisition Corp 1 Class A Ordinary Shares in the global market cap rankings as of August 3, 2026.
Key companies related to Alchemy Investments Acquisition Corp 1 Class A Ordinary Shares by market ranking:
- Twenty One Capital, Inc. (NYSE:XXI): Ranked #7146 globally with a market cap of $1.48 Billion USD.
- Drugs Made In America Acquisition II Corp. Ordinary Shares (NASDAQ:DMII): Ranked #10802 globally with a market cap of $643.37 Million USD.
- Ares Acquisition Corporation II (NYSE:AACT): Ranked #11242 globally with a market cap of $587.05 Million USD.
- Churchill Capital Corp XI (NASDAQ:CCXI): Ranked #11391 globally with a market cap of $568.14 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #7146 | Twenty One Capital, Inc. | NYSE:XXI | $1.48 Billion | $4.27 |
| #10802 | Drugs Made In America Acquisition II Corp. Ordinary Shares | NASDAQ:DMII | $643.37 Million | $10.11 |
| #11242 | Ares Acquisition Corporation II | NYSE:AACT | $587.05 Million | $9.49 |
| #11391 | Churchill Capital Corp XI | NASDAQ:CCXI | $568.14 Million | $13.86 |
Alchemy Investments Acquisition Corp 1 Class A Ordinary Shares Historical Marketcap From 2023 to 2026
Between 2023 and today, Alchemy Investments Acquisition Corp 1 Class A Ordinary Shares's market cap moved from $43.89 Million to $ 50.20 Million, with a yearly change of 5.12%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $50.20 Million | -16.05% |
| 2025 | $59.80 Million | +29.89% |
| 2024 | $46.04 Million | +4.89% |
| 2023 | $43.89 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 3rd, 2026 the market cap of Alchemy Investments Acquisition Corp 1 Class A Ordinary Shares was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $50.20 Million USD |
| MoneyControl | $50.20 Million USD |
| MarketWatch | $50.20 Million USD |
| marketcap.company | $50.20 Million USD |
| Reuters | $50.20 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Alchemy Investments Acquisition Corp 1 Class A Ordinary Shares
Alchemy Investments Acquisition Corp 1 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in Newark, Delaware.